160 related articles for article (PubMed ID: 15969998)
1. Genetics of polycystic ovarian syndrome.
Fratantonio E; Vicari E; Pafumi C; Calogero AE
Reprod Biomed Online; 2005 Jun; 10(6):713-20. PubMed ID: 15969998
[TBL] [Abstract][Full Text] [Related]
2. The genetic basis of polycystic ovary syndrome.
Xita N; Georgiou I; Tsatsoulis A
Eur J Endocrinol; 2002 Dec; 147(6):717-25. PubMed ID: 12457445
[TBL] [Abstract][Full Text] [Related]
3. Current concepts of polycystic ovary syndrome.
Rosenfield RL
Baillieres Clin Obstet Gynaecol; 1997 Jun; 11(2):307-33. PubMed ID: 9536213
[TBL] [Abstract][Full Text] [Related]
4. [Genetic aspects of polycystic ovary syndrome].
Jakubowski L
Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
[TBL] [Abstract][Full Text] [Related]
5. Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.
Calogero AE; Calabrò V; Catanuso M; Condorelli RA; La Vignera S
J Endocrinol Invest; 2011 Sep; 34(8):630-44. PubMed ID: 21606667
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
7. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
10. Obesity and the polycystic ovary syndrome.
Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
[TBL] [Abstract][Full Text] [Related]
11. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.
Strauss JF
Ann N Y Acad Sci; 2003 Nov; 997():42-8. PubMed ID: 14644808
[TBL] [Abstract][Full Text] [Related]
12. Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome.
Cadagan D; Khan R; Amer S
Reprod Biol; 2016 Mar; 16(1):53-60. PubMed ID: 26952754
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome.
Ramos Cirilo PD; Rosa FE; Moreira Ferraz MF; Rainho CA; Pontes A; Rogatto SR
Gynecol Endocrinol; 2012 Mar; 28(3):190-4. PubMed ID: 21824047
[TBL] [Abstract][Full Text] [Related]
15. The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
Chaudhary H; Patel J; Jain NK; Joshi R
J Ovarian Res; 2021 Sep; 14(1):125. PubMed ID: 34563259
[TBL] [Abstract][Full Text] [Related]
16. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome in adolescent girls.
Baldauff NH; Witchel SF
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies.
Barnes RB
J Endocrinol Invest; 1998 Oct; 21(9):567-79. PubMed ID: 9856411
[TBL] [Abstract][Full Text] [Related]
19. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.
Wood JR; Nelson VL; Ho C; Jansen E; Wang CY; Urbanek M; McAllister JM; Mosselman S; Strauss JF
J Biol Chem; 2003 Jul; 278(29):26380-90. PubMed ID: 12734205
[TBL] [Abstract][Full Text] [Related]
20. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.
Wickenheisser JK; Quinn PG; Nelson VL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2000 Jun; 85(6):2304-11. PubMed ID: 10852468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
